We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.45% |
| 2 | Technology | 22.86% |
| 3 | Financials | 11.48% |
| 4 | Communication Services | 7.14% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
TORM
TRMD
$3.98B
| $472K | ﹤0.01% |
+16,528
| New | +$421K |
2026 Q1
0 quarters
|
|
|
TIC
2077
TIC Solutions Inc
TIC
$1.81B
| $471K | ﹤0.01% |
+71,638
| New | +$674K |
2026 Q1
0 quarters
|
|
2078
Iovance Biotherapeutics
IOVA
$6.45B
| $470K | ﹤0.01% |
+133,837
| New | +$428K |
2026 Q1
0 quarters
|
|
2079
NerdWallet
NRDS
$548M
| $466K | ﹤0.01% |
+44,905
| New | +$506K |
2026 Q1
0 quarters
|
|
2080
Alpha and Omega Semiconductor
AOSL
$873M
| $466K | ﹤0.01% |
+21,023
| New | +$457K |
2026 Q1
0 quarters
|
|
2081
Live Oak Bancshares
LOB
$1.68B
| $466K | ﹤0.01% |
+14,086
| New | +$519K |
2026 Q1
0 quarters
|
|
|
LBRDA
2082
DELISTED
Liberty Broadband Class A
LBRDA
| $464K | ﹤0.01% |
+9,248
| New | +$465K |
2026 Q1
0 quarters
|
|
2083
US Physical Therapy
USPH
$1.23B
| $458K | ﹤0.01% |
+6,108
| New | +$500K |
2026 Q1
0 quarters
|
|
2084
First Financial Corp
THFF
$880M
| $457K | ﹤0.01% |
+7,238
| New | +$460K |
2026 Q1
0 quarters
|
|
|
SHOE
2085
Shoe Station Group
SHOE
$345M
| $457K | ﹤0.01% |
+29,285
| New | +$556K |
2026 Q1
0 quarters
|
|
2086
Precigen
PGEN
$2.94B
| $456K | ﹤0.01% |
+117,913
| New | +$484K |
2026 Q1
0 quarters
|
|
|
GLDD
2087
DELISTED
Great Lakes Dredge & Dock
GLDD
| $456K | ﹤0.01% |
+26,816
| New | +$427K |
2026 Q1
0 quarters
|
|
2088
Lincoln Educational Services
LINC
$703M
| $456K | ﹤0.01% |
+11,201
| New | +$353K |
2026 Q1
0 quarters
|
|
2089
Solid Power
SLDP
$539M
| $455K | ﹤0.01% |
+151,739
| New | +$611K |
2026 Q1
0 quarters
|
|
2090
NovoCure
NVCR
$1.85B
| $455K | ﹤0.01% |
+41,761
| New | +$522K |
2026 Q1
0 quarters
|
|
|
MAZE
2091
Maze Therapeutics
MAZE
$1.48B
| $454K | ﹤0.01% |
+15,202
| New | +$671K |
2026 Q1
0 quarters
|
|
2092
Vir Biotechnology
VIR
$1.91B
| $451K | ﹤0.01% |
+50,324
| New | +$401K |
2026 Q1
0 quarters
|
|
2093
NETGEAR
NTGR
$622M
| $450K | ﹤0.01% |
+20,622
| New | +$445K |
2026 Q1
0 quarters
|
|
|
UMH
2094
UMH Properties
UMH
$1.31B
| $450K | ﹤0.01% |
+31,176
| New | +$483K |
2026 Q1
0 quarters
|
|
|
SION
2095
Sionna Therapeutics
SION
$231M
| $449K | ﹤0.01% |
+11,191
| New | +$427K |
2026 Q1
0 quarters
|
|
2096
Clarivate
CLVT
$1.02B
| $448K | ﹤0.01% |
+177,133
| New | +$453K |
2026 Q1
0 quarters
|
|
2097
Wendy's
WEN
$1.19B
| $447K | ﹤0.01% |
+64,254
| New | +$494K |
2026 Q1
0 quarters
|
|
2098
Papa John's
PZZA
$645M
| $446K | ﹤0.01% |
+13,748
| New | +$477K |
2026 Q1
0 quarters
|
|
2099
BW LPG
BWLP
$3.91B
| $444K | ﹤0.01% |
+25,254
| New | +$399K |
2026 Q1
0 quarters
|
|
2100
Xeris Biopharma Holdings
XERS
$1.69B
| $444K | ﹤0.01% |
+76,511
| New | +$507K |
2026 Q1
0 quarters
|
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, followed by Technology and Financials.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.